Fennec Pharmaceuticals Inc. financial data

Symbol
FENC on Nasdaq
Location
Po Box 13628, 68 Tw Alexander Drive, Research Triangle Park, NC
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 519 % -21.4%
Debt-to-equity -882 % +42.7%
Return On Equity 117 % +291%
Return On Assets -15 % -620%
Operating Margin -12 % -452%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 28.1M shares +2.5%
Common Stock, Shares, Outstanding 28.1M shares +2.33%
Entity Public Float 82.2M USD -40.4%
Common Stock, Value, Issued 148M USD +1.52%
Weighted Average Number of Shares Outstanding, Basic 27.9M shares +1.89%
Weighted Average Number of Shares Outstanding, Diluted 27.9M shares +1.89%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 38.8M USD -21.4%
Research and Development Expense 280K USD -3.11%
Selling and Marketing Expense 16.5M USD -10.3%
General and Administrative Expense 24M USD -6.88%
Operating Income (Loss) -4.66M USD -377%
Nonoperating Income (Expense) -1.91M USD +32.1%
Net Income (Loss) Attributable to Parent -6.94M USD -513%
Earnings Per Share, Basic 0 USD/shares -733%
Earnings Per Share, Diluted 0 USD/shares -111%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 21.9M USD -45.6%
Other Assets, Current 898K USD +64.5%
Assets, Current 46.1M USD -20.5%
Operating Lease, Right-of-Use Asset 29K USD
Other Assets, Noncurrent 743K USD -22.3%
Assets 49.3M USD -16.4%
Accounts Payable, Current 5.87M USD +51.7%
Accrued Liabilities, Current 3.7M USD +11.7%
Contract with Customer, Liability, Current 248K USD 0%
Liabilities, Current 9.82M USD +32%
Contract with Customer, Liability, Noncurrent 24.6M USD 0%
Operating Lease, Liability, Noncurrent 2K USD
Liabilities 53.8M USD -16.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1.24M USD 0%
Retained Earnings (Accumulated Deficit) -225M USD -3.19%
Stockholders' Equity Attributable to Parent -4.49M USD +13.1%
Liabilities and Equity 49.3M USD -16.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.32M USD -111%
Net Cash Provided by (Used in) Financing Activities 359K USD
Common Stock, Shares, Issued 28.1M shares +2.33%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.96M USD -110%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 21.9M USD -45.6%
Deferred Tax Assets, Valuation Allowance 52.4M USD +28.6%
Deferred Tax Assets, Gross 52.4M USD +28.6%
Operating Lease, Liability 7K USD
Lessee, Operating Lease, Liability, to be Paid 5K USD
Operating Lease, Liability, Current 2K USD -90.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 5K USD
Deferred Tax Assets, Operating Loss Carryforwards 13.2M USD -64.4%
Deferred Tax Assets, Net of Valuation Allowance 26K USD 0%